Literature DB >> 18451668

From uremic toxin retention to removal by convection: do we know enough?

R Vanholder1, N Meert, E Schepers, G Glorieux.   

Abstract

The uremic syndrome is defined by a complex clinical picture, characterized by the dysfunction of most organs which are affected by the retention of multiple solutes. Recent research has helped to unravel the pathophysiology and to identify several as yet unknown responsible compounds. In this publication, we summarize which compounds play the most important pathophysiologic role, and which dialysis strategies can be considered to decrease their concentration and improve outcomes. The main pathophysiologic role is played by molecules which are so-called 'difficult to remove by dialysis'. Essentially observational studies have suggested that enhancement of removal of these molecules, by improving convection (hemodiafiltration), creates an improvement of survival. The knowledge of uremic toxicity is still far from complete however, and we need extra information about responsible compounds and mechanisms, eventually leading to a classification of the most important culprits, to allow the development of even more efficient or specific removal strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451668     DOI: 10.1159/000130657

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  3 in total

1.  Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram.

Authors:  Alida Páll; Árpád Czifra; Veronika Sebestyén; Gergely Becs; Csaba Kun; József Balla; György Paragh; István Lőrincz; Dénes Páll; Tamás János Padra; Anupam Agarwal; Abolfazl Zarjou; Zoltán Szabó
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

2.  Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function.

Authors:  Arpád Czifra; Alida Páll; Julianna Kulcsár; Kitti Barta; Attila Kertész; György Paragh; István Lőrincz; Zoltán Jenei; Anupam Agarwal; Abolfazl Zarjou; József Balla; Zoltán Szabó
Journal:  BMC Nephrol       Date:  2013-04-02       Impact factor: 2.388

3.  Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.

Authors:  Krisztina Pénzes; Boglárka Hurják; Éva Katona; Gergely Becs; József Balla; László Muszbek
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.